BDBM259813 US9505766, 13

SMILES NC(=O)C(=C\c1ccc2[nH]ncc2c1)\C#N

InChI Key InChIKey=JIMIDTDLZHFIJW-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 259813   

TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
University of California

US Patent
LigandPNGBDBM259813(US9505766, 13)
Affinity DataIC50: 250nMpH: 8.0 T: 2°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetRibosomal protein S6 kinase alpha-3 [399-740,C436V](Human)
University of California

US Patent
LigandPNGBDBM259813(US9505766, 13)
Affinity DataIC50: 1.50E+5nMpH: 8.0 T: 2°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase Nek2 [T175A](Human)
University of California

US Patent
LigandPNGBDBM259813(US9505766, 13)
Affinity DataIC50: 3.00E+3nMpH: 7.6 T: 2°CAssay Description:For RSK2 kinase assays, see Example 64 above. Full-length human T175A NEK2 (referred to as NEK2) was expressed and purified as previously described (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase Nek2 [C22A](Human)
University of California

US Patent
LigandPNGBDBM259813(US9505766, 13)
Affinity DataIC50: 1.00E+4nMpH: 7.6 T: 2°CAssay Description:For RSK2 kinase assays, see Example 64 above. Full-length human T175A NEK2 (referred to as NEK2) was expressed and purified as previously described (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/27/2017
Entry Details
Go to US Patent